Triple

T184501
Position Surface form Disambiguated ID Type / Status
Subject European Medicines Agency E3950 entity
Predicate hasCommittee P1396 FINISHED
Object Committee for Medicinal Products for Veterinary Use
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
E24385 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Committee for Medicinal Products for Veterinary Use | Statement: [European Medicines Agency, hasCommittee, Committee for Medicinal Products for Veterinary Use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Committee for Medicinal Products for Veterinary Use
Context triple: [European Medicines Agency, hasCommittee, Committee for Medicinal Products for Veterinary Use]
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • C. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. UK Medicines and Healthcare products Regulatory Agency
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Committee for Medicinal Products for Veterinary Use
Triple: [European Medicines Agency, hasCommittee, Committee for Medicinal Products for Veterinary Use]
Generated description
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Committee for Medicinal Products for Veterinary Use
Target entity description: The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
  • A. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • B. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • C. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. UK Medicines and Healthcare products Regulatory Agency
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a25497e2f08190a040f8c6e1842643 completed Feb. 28, 2026, 2:36 a.m.
NER Named-entity recognition batch_69a25926be9c8190a4cfce66f57589d1 completed Feb. 28, 2026, 2:55 a.m.
NED1 Entity disambiguation (via context triple) batch_69a30cc5130c81908346cf86a23a6285 completed Feb. 28, 2026, 3:41 p.m.
NEDg Description generation batch_69a30d568260819094295ac1ce1b05d1 completed Feb. 28, 2026, 3:44 p.m.
NED2 Entity disambiguation (via description) batch_69a30da5f1e0819090e06fa7caff1767 completed Feb. 28, 2026, 3:45 p.m.
Created at: Feb. 28, 2026, 2:40 a.m.